Fumaric Acid

Fumaric Acid

SCHEMBL28077289

Nc1ccc(S(N)(=O)=O)c(-c2ccc3ccncc3c2)c1.O.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PRKCZ Q05513 1/20 0.47
CCNC P24863 10/20 0.45
CDK8 P49336 10/20 0.45
F10 P00742 1/20 0.40
CYP3A4 P08684 1/20 0.38
SLC22A12 Q96S37 1/20 0.36
AR P10275 1/20 0.36
LCK P06239 1/20 0.36
CSF1R P07333 1/20 0.36
KDR P35968 1/20 0.36
MAPK14 Q16539 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28077291 0.90 PRKCZ (0.57) PRKCZF10CYP3A4
Fumaric Acid SCHEMBL28077347 0.80 CCNC (0.41) CCNCCDK8CYP3A4MAPK14
SCHEMBL11882155 0.71 AKT1 (0.44)
SCHEMBL2887108 0.69 PRKCZ (0.64) PRKCZCYP3A4ARLCKCSF1R
Hydrochloric Acid SCHEMBL2891147 0.68 PRKCZ (0.62) PRKCZCYP3A4ARLCKCSF1R
SCHEMBL671916 0.68 CA1 (0.50) F10CYP3A4
SCHEMBL8012548 0.68 CA1 (0.51) F10
SCHEMBL7698483 0.67 KDM4E (0.56) ARLCK
SCHEMBL28077283 0.67 ALDH1A1 (0.45) CCNCCDK8MAPK14
SCHEMBL30279711 0.66 PRKCZ (0.71) PRKCZCYP3A4KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105764510-A An H3 receptor antagonist combined with a cholinesterase inhibitor for use in the treatment of alzheimer's disease 赛诺菲 2016-07-13 CN disclosed